Transcription factor IRF5 drives P2X4R+-reactive microglia gating neuropathic pain

Abstract

In response to neuronal injury or disease, microglia adopt distinct reactive phenotypes via the expression of different sets of genes. Spinal microglia expressing the purinergic P2X4 receptor (P2X4R) after peripheral nerve injury (PNI) are implicated in neuropathic pain. Here we show that interferon regulatory factor-5 (IRF5), which is induced in spinal microglia after PNI, is responsible for direct transcriptional control of P2X4R. Upon stimulation of microglia by fibronectin, IRF5 induced de novo expression of P2X4R by directly binding to the promoter region of the P2rx4 gene. Mice lacking Irf5 did not upregulate spinal P2X4R after PNI, and also exhibited substantial resistance to pain hypersensitivity. Furthermore, we found that expression of IRF5 in microglia is regulated by IRF8. Thus, an IRF8-IRF5 transcriptional axis may contribute to shifting spinal microglia toward a P2X4R-expressing reactive state after PNI. These results may provide a new target for treating neuropathic pain.

References 50

1. 1.

   Hanisch U. K. & Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387–1394 (2007 ).

   Not in our library10.1038/nn1997

2. 2.

   Graeber M. B. Changing face of microglia. Science 330, 783–788 (2010 ).

   Not in our library10.1126/science.1190929

3. 3.

   Ransohoff R. M. & Cardona A. E. The myeloid cells of the central nervous system parenchyma. Nature 468, 253–262 (2010 ).

   Not in our library10.1038/nature09615

4. 4.

   Perry V. H., Nicoll J. A. & Holmes C. Microglia in neurodegenerative disease. Nat. Rev. Neurol. 6, 193–201 (2010 ).

   Not in our library10.1038/nrneurol.2010.17

5. 5.

   Glass C. K., Saijo K., Winner B., Marchetto M. C. & Gage F. H. Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918–934 (2010 ).

   Not in our library10.1016/j.cell.2010.02.016

6. 6.
   Factors regulating microglia activation · 2013

   No notice
7. 7.

   Tsuda M., Masuda T., Tozaki-Saitoh H. & Inoue K. Microglial regulation of neuropathic pain. J. Pharmacol. Sci. 121, 89–94 (2013 ).

   Not in our library10.1254/jphs.12r14cp

8. 8.

   Masuda T. et al. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep. 1, 334–340 (2012 ).

   Not in our library10.1016/j.celrep.2012.02.014

9. 9.

   McMahon S. B. & Malcangio M. Current challenges in glia-pain biology. Neuron 64, 46–54 (2009 ).

   Not in our library10.1016/j.neuron.2009.09.033

10. 10.

    Tsuda M., Inoue K. & Salter M. W. Neuropathic pain and spinal microglia: a big problem from molecules in ‘small’ glia. Trends Neurosci. 28, 101–107 (2005 ).

    Not in our library10.1016/j.tins.2004.12.002

11. 11.

    von Hehn C. A., Baron R. & Woolf C. J. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 73, 638–652 (2012 ).

    Not in our library10.1016/j.neuron.2012.02.008

12. 12.

    Tsuda M. et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778–783 (2003 ).

    Not in our library10.1038/nature01786

13. 13.

    Beggs S., Trang T. & Salter M. W. P2X4R+ microglia drive neuropathic pain. Nat. Neurosci. 15, 1068–1073 (2012 ).

    Not in our library10.1038/nn.3155

14. 14.

    Coull J. A. et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438, 1017–1021 (2005 ).

    Not in our library10.1038/nature04223

15. 15.

    Trang T., Beggs S. & Salter M. W. ATP receptors gate microglia signaling in neuropathic pain. Exp. Neurol. 234, 354–361 (2012 ).

    Not in our library10.1016/j.expneurol.2011.11.012

16. 16.

    Ulmann L. et al. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 28, 11263–11268 (2008 ).

    Not in our library10.1523/jneurosci.2308-08.2008

17. 17.

    Takaoka A. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243–249 (2005 ).

    Not in our library10.1038/nature03308

18. 18.

    Krausgruber T. et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231–238 (2011 ).

    Not in our library10.1038/ni.1990

19. 19.

    Tamura T., Yanai H., Savitsky D. & Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535–584 (2008 ).

    Not in our library10.1146/annurev.immunol.26.021607.090400

20. 20.

    Negishi H. et al. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat. Immunol. 13, 659–666 (2012 ).

    Not in our library10.1038/ni.2307

21. 21.

    Rivest S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 9, 429–439 (2009 ).

    Not in our library10.1038/nri2565

22. 22.

    Tsuda M. et al. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc. Natl Acad. Sci. USA 106, 8032–8037 (2009 ).

    Not in our library10.1073/pnas.0810420106

23. 23.

    Inoue K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol. Ther. 109, 210–226 (2006 ).

    Not in our library10.1016/j.pharmthera.2005.07.001

24. 24.

    Davalos D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752–758 (2005 ).

    Not in our library10.1038/nn1472

25. 25.

    Nasu-Tada K., Koizumi S., Tsuda M., Kunifusa E. & Inoue K. Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X4, a key molecule for mechanical allodynia. Glia 53, 769–775 (2006 ).

    Not in our library10.1002/glia.20339

26. 26.

    Tsuda M. et al. Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia 56, 579–585 (2008 ).

    Not in our library10.1002/glia.20641

27. 27.

    Price J. & Hynes R. O. Astrocytes in culture synthesize and secrete a variant form of fibronectin. J. Neurosci. 5, 2205–2211 (1985 ).

    Not in our library10.1523/jneurosci.05-08-02205.1985

28. 28.

    Echeverry S., Shi X. Q., Rivest S. & Zhang J. Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway. J. Neurosci. 31, 10819–10828 (2011 ).

    Not in our library10.1523/jneurosci.1642-11.2011

29. 29.

    Tsuda M., Toyomitsu E., Kometani M., Tozaki-Saitoh H. & Inoue K. Mechanisms underlying fibronectin-induced up-regulation of P2X4R expression in microglia: distinct roles of PI3K-Akt and MEK-ERK signalling pathways. J. Cell Mol. Med. 13, 3251–3259 (2009 ).

    Not in our library10.1111/j.1582-4934.2009.00719.x

30. 30.

    Tamura T., Nagamura-Inoue T., Shmeltzer Z., Kuwata T. & Ozato K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13, 155–165 (2000 ).

    Not in our library10.1016/s1074-7613(00)00016-9

31. 31.

    Kurotaki D. et al. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation. Blood 121, 1839–1849 (2013 ).

    Not in our library10.1182/blood-2012-06-437863

32. 32.

    Tsuda M. et al. Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 56, 50–58 (2008 ).

    Not in our library10.1002/glia.20591

33. 33.

    Clark A. K. et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Natl Acad. Sci. USA 104, 10655–10660 (2007 ).

    Not in our library10.1073/pnas.0610811104

34. 34.

    Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov. 7, 575–590 (2008 ).

    Not in our library10.1038/nrd2605

35. 35.

    Inoue K. & Tsuda M. Microglia and neuropathic pain. Glia 57, 1469–1479 (2009 ).

    Not in our library10.1002/glia.20871

36. 36.

    Chen Z. J. & Sun L. J. Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 33, 275–286 (2009 ).

    Not in our library10.1016/j.molcel.2009.01.014

37. 37.

    Balkhi M. Y., Fitzgerald K. A. & Pitha P. M. Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Mol. Cell Biol. 28, 7296–7308 (2008 ).

    Not in our library10.1128/mcb.00662-08

38. 38.

    Deng L. et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351–361 (2000 ).

    Not in our library10.1016/s0092-8674(00)00126-4

39. 39.

    Zhao J. et al. IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J. Biol. Chem. 281, 10073–10080 (2006 ).

    Not in our library10.1074/jbc.m507788200

40. 40.

    Ransohoff R. M. & Perry V. H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119–145 (2009 ).

    Not in our library10.1146/annurev.immunol.021908.132528

41. 41.

    Starossom S. C. et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37, 249–263 (2012 ).

    Not in our library10.1016/j.immuni.2012.05.023

42. 42.

    Miron V. E. et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16, 1211–1218 (2013 ).

    Not in our library10.1038/nn.3469

43. 43.

    Couzinet A. et al. A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis. Proc. Natl Acad. Sci. USA 105, 2556–2561 (2008 ).

    Not in our library10.1073/pnas.0712295105

44. 44.
    Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physiological phenotype of microglia · 2012

    Not checked
45. 45.

    Minten C., Terry R., Deffrasnes C., King N. J. & Campbell I. L. IFN regulatory factor 8 is a key constitutive determinant of the morphological and molecular properties of microglia in the CNS. PLoS One 7, e49851 (2012 ).

    Not in our library10.1371/journal.pone.0049851

46. 46.

    Holtschke T. et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87, 307–317 (1996 ).

    Not in our library10.1016/s0092-8674(00)81348-3

47. 47.

    Kim S. H. & Chung J. M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355–363 (1992 ).

    Not in our library10.1016/0304-3959(92)90041-9

48. 48.

    Tozaki-Saitoh H. et al. P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J. Neurosci. 28, 4949–4956 (2008 ).

    Not in our library10.1523/jneurosci.0323-08.2008

49. 49.

    Masuda T., Tsuda M., Tozaki-Saitoh H. & Inoue K. Lentiviral transduction of cultured microglia. Methods Mol. Biol. 1041, 63–67 (2013 ).

    Not in our library10.1007/978-1-62703-520-0_8

50. 50.

    Chaplan S. R., Bach F. W., Pogrel J. W., Chung J. M. & Yaksh T. L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53, 55–63 (1994 ).

    Not in our library10.1016/0165-0270(94)90144-9

Cited by papers we hold 5

• Microencapsulated Neural Stem Cells Inhibit Sciatic Nerve Injury-Induced Pain by Reducing P2 × 4 Receptor Expression · 2021
  Not checked
• miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis · 2018
  No notice
• P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis · 2018
  No notice
• P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology · 2017
  No notice
• Dorsal horn neurons release extracellular ATP in a VNUT-dependent manner that underlies neuropathic pain · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.